Insulet Corporation
NASDAQ:PODDMedical - Devices
-$4.17 today
- Market cap
- $9.71B
- Beta
- 1.13
- P/E (TTM)
- 33.2
- EPS (TTM)
- $4.33
Volume 2.09M
Average 1.32M
PODD Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Insulet CorporationNASDAQ: PODD
Revenue · Q2 FY2026 · quarter ended Jun 2026
Revenue grows, but more slowly than its trailing trend
Q2 FY2026 revenue of $801.7M rose 23.5% year over year, behind the +29.4% change in trailing-twelve-month revenue. Sequentially, it rose 5.3% from the prior quarter. Over 3 fiscal years it compounded at +27.5% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 19 analysts of $3.31B (+22.1%) for the fiscal year ending Dec 2026, a slowdown from the +30.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $801.7M+5.3% QoQ
- Last fiscal yearDec 2025
- $2.71B+30.7% YoY
- LTMJun 2026
- $3.05B+29.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +23.5% | +17.9% | -5.6 pp |
| 1 year | +30.7% | +22.1% | -8.7 pp |
| 3-year CAGR | +27.5% | +15.1% | -12.4 pp |
| 5-year CAGR | +12.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 2.71B USD
- Year-over-year change
- +30.7%
- 4-year CAGR
- +25.3%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.71B | +30.7% |
| FY2024 | 2024-12-31 | 2.07B | +22.1% |
| FY2023 | 2023-12-31 | 1.7B | +30.0% |
| FY2022 | 2022-12-31 | 1.31B | +18.8% |
| FY2021 | 2021-12-31 | 1.1B | — |
Revenue vs competitors
How PODD compares with its peers on the latest reported figures
- PODD's LTM Jun 2026 revenue of $3.05B is the 2nd highest of the 5 companies compared; the peer median is $568.89M.
- Its year-over-year change of +29.4% is the 3rd highest of 5, against a peer median of +36.7%.
- Over three fiscal years its annual growth of +27.5% compares with a peer median of +23.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $4.97B | +15.5% | +17.0% | |
| LTM Jun 2026 | $3.05B | +29.4% | +27.5% | |
| LTM Mar 2026 | $1.03B | -6.8% | +8.2% | |
| LTM Mar 2026 | $110.24M | +57.9% | +724.3% | |
| LTM Mar 2026 | $40.71M | +71.9% | +29.1% | |
| Peer median (excluding PODD) | $568.89M | +36.7% | +23.1% | |
Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 1.31B | 1.7B | 2.07B | 2.71B |
| Cost of Revenue | 346.7M | 499.7M | 537.2M | 625.9M | 768.2M |
| Gross Profit | 752.1M | 805.6M | 1.16B | 1.45B | 1.94B |
| Gross Margin | 68.4% | 61.7% | 68.3% | 69.8% | 71.6% |
| Research & Development | 160.1M | 180.2M | 205M | 219.6M | 301.1M |
| Selling, General & Admin | 466M | 587.8M | 734.9M | 917.2M | 1.17B |
| Operating Expenses | 626.1M | 768M | 939.9M | 1.14B | 1.47B |
| Depreciation & Amortization | 57.4M | 63.2M | 72.8M | 80.8M | 90.4M |
| EBITDA | 139.6M | 109M | 323.6M | 423.7M | 509.6M |
| EBITDA Margin | 12.7% | 8.4% | 19.1% | 20.5% | 18.8% |
| Operating Income | 126M | 37.6M | 220M | 308.9M | 473.8M |
| Operating Margin | 11.5% | 2.9% | 13.0% | 14.9% | 17.5% |
| Interest Income | 500K | 9.3M | 28.6M | 39.5M | 34.7M |
| Interest Expense | 61.7M | 36M | 36.2M | 42.7M | 79.7M |
| Other Income / Expenses | (105.5M) | (27.8M) | (5.4M) | (8.7M) | (134.3M) |
| Income Before Tax | 20.5M | 9.8M | 214.6M | 300.2M | 339.5M |
| Pre-Tax Margin | 1.9% | 0.8% | 12.6% | 14.5% | 12.5% |
| Income Tax Expense | 3.7M | 5.2M | 8.3M | (118.1M) | 92.4M |
| Net Income | 16.8M | 4.6M | 206.3M | 418.3M | 247.1M |
| Net Margin | 1.5% | 0.4% | 12.2% | 20.2% | 9.1% |
| EPS (Basic) | 0.25 | 0.07 | 2.96 | 5.97 | 3.51 |
| EPS (Diluted) | 0.25 | 0.07 | 2.94 | 5.78 | 3.48 |
| Weighted Avg Shares | 67.7M | 69.38M | 69.75M | 70.08M | 70.35M |
| Weighted Avg Shares (Diluted) | 68.58M | 69.91M | 73.63M | 73.89M | 71.89M |
Insulet Corporation
NASDAQ:PODD
Intrinsic Alpha fair value
Locked
Current Price
$139.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.